- Home
- Publications
- Publication Search
- Publication Details
Title
WLS-Wnt signaling promotes neuroendocrine prostate cancer
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 1, Pages 101970
Publisher
Elsevier BV
Online
2021-01-01
DOI
10.1016/j.isci.2020.101970
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ONECUT2 is a driver of neuroendocrine prostate cancer
- (2019) Haiyang Guo et al. Nature Communications
- Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
- (2019) Cora N Sternberg Future Oncology
- Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer
- (2019) Pedro Isaacsson Velho et al. EUROPEAN UROLOGY
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
- (2019) Mark P. Labrecque et al. JOURNAL OF CLINICAL INVESTIGATION
- TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
- (2019) Geun Taek Lee et al. PLoS One
- Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer
- (2019) Lavanya Moparthi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancer
- (2019) Xiaoliang Chen et al. PROSTATE
- WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages
- (2018) Geun Taek Lee et al. BRITISH JOURNAL OF CANCER
- Inhibition of the Wnt/β-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer
- (2018) Zhuangzhuang Zhang et al. CANCER RESEARCH
- ERAD‐dependent control of the Wnt secretory factor Evi
- (2018) Kathrin Glaeser et al. EMBO JOURNAL
- Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
- (2018) Stefanie Thiele et al. Oncotarget
- Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
- (2018) Chengfei Liu et al. Nature Communications
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- FOXA1 inhibits prostate cancer neuroendocrine differentiation
- (2017) J Kim et al. ONCOGENE
- Ectopic repression of receptor tyrosine kinase–like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial–mesenchymal transition
- (2017) Ying Xu et al. TUMOR BIOLOGY
- Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin
- (2017) Sebastian C. Schmid et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis
- (2017) Koran S. Harris et al. Stem Cells International
- SOX9 drives WNT pathway activation in prostate cancer
- (2016) Fen Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
- (2015) C. Liu et al. CANCER RESEARCH
- Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT
- (2015) Joseph A. Bisson et al. DEVELOPMENTAL BIOLOGY
- RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
- (2015) D. T. Miyamoto et al. SCIENCE
- Enzalutamide for patients with metastatic castration-resistant prostate cancer
- (2015) Wijdan Ramadan et al. OncoTargets and Therapy
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Protein Kinase Cδ Is a Therapeutic Target in Malignant Melanoma with NRAS Mutation
- (2014) Asami Takashima et al. ACS Chemical Biology
- Aggressive Variants of Castration-Resistant Prostate Cancer
- (2014) H. Beltran et al. CLINICAL CANCER RESEARCH
- WLS Retrograde Transport to the Endoplasmic Reticulum during Wnt Secretion
- (2014) Jia Yu et al. DEVELOPMENTAL CELL
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Evolution of androgen receptor targeted therapy for advanced prostate cancer
- (2014) Yien Ning Sophia Wong et al. Nature Reviews Clinical Oncology
- Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway
- (2013) Dhruv Kumar et al. CANCER LETTERS
- Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small-Cell Lung Cancer
- (2013) Yuhchyau Chen et al. Journal of Thoracic Oncology
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
- (2012) Anna V Lapuk et al. JOURNAL OF PATHOLOGY
- Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis
- (2012) H.-Y. H. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis
- (2011) Iris Augustin et al. EMBO Molecular Medicine
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes
- (2011) A. Aparicio et al. Cancer Discovery
- Regulation of Villin by Wnt5a/Ror2 Signaling in Human Intestinal Cells
- (2011) Rebecca Cheung et al. Frontiers in Physiology
- Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors
- (2010) Jianfei Qi et al. CANCER CELL
- Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
- (2010) Pinar Uysal-Onganer et al. Molecular Cancer
- Wnt signal transduction pathways
- (2010) Yuko Komiya et al. Organogenesis
- Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation
- (2009) J. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started